Petros Pharmaceuticals, Inc.
USD0.01
-0.00 (-15.00%)
CEO
Joshua N. Silverman
IPO Date
2020-12-02
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$0.01
Prev. Close
$0.01
Day Low
$0.01
Day High
$0.01
52W Low
$0.00
52W High
$0.04
Market Cap
$0.00B
Volume
0.19M
| -5.5 |
| 31 Dec 2023 | FY | 72.0% | -140.2% | -65.4% | -24.2% | 0.66 | 1.89 | -5.6 |
| 31 Dec 2022 | FY | 61.8% | -334.4% | -120.0% | -61.8% | 0.59 | 2.08 | -6.0 |
| 31 Dec 2021 | FY | 79.5% | -115.0% | -25.3% | -13.3% | 0.01 | 0.99 | -100.9 |
| 31 Dec 2020 | FY | 57.7% | -215.3% | -117.8% | -29.5% | 0.45 | 0.62 | -28.5 |
| 31 Dec 2019 | FY | 18.4% | -208.7% | -405.4% | -55.7% | 1.71 | 0.29 | -7.5 |
| 31 Dec 2018 | FY | 25.4% | -231.1% | 1931.4% | -48.5% | -28.07 | 0.41 | -3.1 |
| -1.7 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -27.4% | -15.0% | 0.00 | 2.22 | -0.3 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | 122.2% | 73.4% | 0.00 | 2.51 | 0.0 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | 23.6% | -12.8% | 0.00 | 0.53 | -0.2 |
| 31 Dec 2024 | Q4 | 63.5% | -1278.4% | 124.2% | -87.2% | -0.99 | 0.40 | -21.3 |
| 30 Sept 2024 | Q3 | 81.8% | -140.9% | -71.2% | -10.7% | 2.35 | 0.85 | -4.2 |
| 30 Jun 2024 | Q2 | 76.8% | -46.6% | -7.2% | -2.6% | 0.84 | 1.40 | -7.3 |
| 31 Mar 2024 | Q1 | 24.4% | -155.7% | -20.2% | -7.1% | 0.76 | 1.60 | -5.2 |
| 31 Dec 2023 | Q4 | 143.4% | -87.3% | 2.5% | 0.9% | 0.66 | 1.89 | 4.2 |